Physician profile
Trevor Downing
NPI 1447929666
$823.42
in general payments reported to CMS, 2019-2025
14 companies · $762 in 2025
The $762 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $61.64 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $252.16 | 2024-2025 | |
| Braeburn INC. | $88.97 | 2025 | Brixadi |
| Indivior INC. | $81.51 | 2025 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $65.29 | 2024-2025 | Uzedy |
| Xeris Pharmaceuticals, INC. | $60.97 | 2025 | Gvoke Hypopen |
| Medtronic, INC. | $60.96 | 2025 | Venaseal |
| Gilead Sciences, INC. | $58.65 | 2024-2025 | |
| Lundbeck LLC | $37.46 | 2025 | Rexulti |
| Alkermes, INC. | $26.72 | 2025 | Vivitrol |
| Neurocrine Biosciences, INC. | $21.58 | 2025 | |
| Exact Sciences Corporation | $20.04 | 2025 | The Cologuard Plus Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.84 | 2025 | Caplyta |
| Glaxosmithkline, LLC. | $15.74 | 2025 | Bexsero |
| Dexcom, INC. | $14.53 | 2025 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Downing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.